Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Plasma Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00838513
What this trial is testing

Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Alexion Pharmaceuticals, Inc. 15
Not applicableStudy completedNCT02167113
What this trial is testing

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

Who this might be right for
Hepatitis B, Chronic
Hologic, Inc. 331
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Not applicableNot Yet RecruitingNCT07312942
What this trial is testing

Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma

Who this might be right for
Multiple MyelomaBreathing TechniquesBreathing Exercises+2 more
Universidad Complutense de Madrid 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Not applicableUnknownNCT04015570
What this trial is testing

Efficacy and Safety of Plasma Exchange Compared to Standard Medical Therapy in Patients With Severe Drug Induced Liver Injury With or Without Underlying Chronic Liver Disease.

Who this might be right for
Chronic Liver Disease
Institute of Liver and Biliary Sciences, India 30
Testing effectiveness (Phase 2)Looking for participantsNCT07181941
What this trial is testing

Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
Fred Hutchinson Cancer Center 30
Early research (Phase 1)UnknownNCT03767725
What this trial is testing

Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma in Relapse
Shenzhen Second People's Hospital 10
Post-approval studies (Phase 4)UnknownNCT04016727
What this trial is testing

Variation in Rate of Orthodontic Tooth Movement in Response to Platelet Rich Plasma Therapy

Who this might be right for
Tooth Movement
Armed Forces Institute of Dentistry, Pakistan 10
Not applicableStudy completedNCT03091127
What this trial is testing

Real-world Use of Carfilzomib Among Multiple Myeloma Patients in Europe

Who this might be right for
Multiple Myeloma
Amgen 705
Large-scale testing (Phase 3)Looking for participantsNCT07649525
What this trial is testing

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)
University of Leeds 1,226
Testing effectiveness (Phase 2)Looking for participantsNCT06581640
What this trial is testing

Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapsed/Refractory
The First Affiliated Hospital of Xiamen University 5
Early research (Phase 1)Study completedNCT00990717
What this trial is testing

Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
University Health Network, Toronto 8
Not applicableEnrolling By InvitationNCT04210791
What this trial is testing

Autologous Stem Cell Transplantation for Patients With AL Amyloidosis

Who this might be right for
AL AmyloidosisPlasma Cell Dyscrasia
Nanjing University School of Medicine 500
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Testing effectiveness (Phase 2)Looking for participantsNCT07087860
What this trial is testing

Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers

Who this might be right for
Metastatic Bladder Urothelial CarcinomaMetastatic Renal Pelvis and Ureter Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+3 more
Mayo Clinic 70
Not applicableNot Yet RecruitingNCT07259525
What this trial is testing

Escitalopram Plasma Concentrations in Premenopausal and Postmenopausal Women

Who this might be right for
Therapeutic Drug Monitoring (TDM)MenopauseDepression - Major Depressive Disorder+1 more
Eskisehir Osmangazi University 94
Not applicableNot Yet RecruitingNCT07553689
What this trial is testing

Plasma Therapy for Diverse Wounds

Who this might be right for
Wound Care
First Affiliated Hospital, Sun Yat-Sen University 1,000
Large-scale testing (Phase 3)Enrolling By InvitationNCT06893250
What this trial is testing

Orthobiologic Treatment for Knee Osteoarthritis

Who this might be right for
Osteoarthritis Knee
University Hospital of North Norway 160
Large-scale testing (Phase 3)Study completedNCT02195479
What this trial is testing

Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 706
Next Page